Cardiff's senior scientists to advise Capital Medical University’s Key Laboratory

Professor Xiaomin Wang, Capital Medicals Vice President said:

“We are honoured to have three distinguished Senior Scientists from Cardiff University on the Advisory Panel for the Key Laboratory. Their presence will strengthen the long term collaboration between the two institutions and support Capital Medical’s wider cancer research agenda.”

Capital Medical University ranks amount the top academic medical institutions in China, and since 2014 has been awarded the status of a Key Laboratory for cancer research by the Beijing Government. Cardiff University’s Nobel Prize winning Chancellor - Sir Martin Evans FRS, Head of Oncology and Palliative Medicine - Professor Malcolm Mason and Director of Cardiff China Medical Research Collaboration – Professor Wen G Jiang, will sit on the Advisory Panel for the Key Laboratory.

Research-led collaborations have been in place between the two universities for the past decade. Work has seen the creation of the Cardiff-CMU Joint Centre for Biomedical Research, joint research grants, and the exchange of research scholars and postgraduate students.

The Advisory Panel, which joins together UK and Chinese Scientists, including Academician, and Panel Chairman, Shujun Cheng of the Chinese Academy of Sciences (CAS), will enhance the collaboration between Cardiff University and Capital Medical. It is hoped that Cardiff University’s representation and presence on the panel, will lead to more initiatives and achievements in cancer research, including in the areas of wound healing and infection and immunity.

Professor Dylan Jones, Pro Vice-Chancellor, College of Biomedical & Life Sciences said:

‘The relationship between Cardiff and China is very important. We hope that the link between Cardiff University and Capital Medical will go from strength to strength. The presence of three of our Scientists on the Advisory Panel will continue to nurture the relationship between the institutions.’